Melanie Leitner is the Chief Scientific Officer for the ALS Investment Fund and the founder of Accelerating NeuroVentures, LLC. With extensive experience in the neuroscience field, she provides strategic and business development services to investors and biopharma companies, focusing on funding and advancing programs in the neuroscience translational space.